Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Vanda Pharmaceuticals Inc. (VNDA)  
$4.62 0.14 (3.12%) as of 4:30 Fri 4/26


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 61,398,000
Market Cap: 283.66(M)
Last Volume: 821,939 Avg Vol: 693,736
52 Week Range: $3.38 - $6.95
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ COMPOSITE     NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  803
Guru Rank Value     : 1
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Vanda Pharmaceuticals is a biopharmaceutical company. Co.'s commercial portfolio is comprised of two products, HETLIOZ® for the treatment of Non-24 Sleep-Wake Disorder (Non-24) and nighttime sleep disturbances in Smith-Magenis Syndrome and Fanapt® for the treatment of schizophrenia. In addition, Co. has a number of drugs in development, including: Tradipitant (VLY-686), a small molecule neurokinin-1 receptor antagonist, for the treatment of gastroparesis, motion sickness, atopic dermatitis, and COVID-19 pneumonia; and VTR-297, a small molecule histone deacetylase inhibitor for the treatment of hematologic malignancies and with potential use as a treatment for several oncology indications.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 121,098 121,098 148,134 388,157
Total Sell Value $513,345 $513,345 $684,141 $2,735,436
Total People Sold 5 5 6 8
Total Sell Transactions 10 10 14 33
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 549
  Page 10 of 22  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Polymeropoulos Mihael Hristos President and CEO   •       •      –    2017-03-01 4 A $0.00 $0 D/D 200,000 1,041,848     -
   Reverberi Gian Piero SVP & Chief Commercial Officer   •       –      –    2017-03-01 4 A $0.00 $0 D/D 30,000 50,000     -
   Kelly James Patrick SVP, CFO & Treasurer   •       –      –    2017-01-03 4 S $15.51 $169,013 D/D (10,895) 69,721     -
   Kelly James Patrick SVP, CFO & Treasurer   •       –      –    2017-01-03 4 OE $0.00 $0 D/D 19,844 80,616     -
   Reverberi Gian Piero SVP & Chief Commercial Officer   •       –      –    2017-01-03 4 OE $0.00 $0 D/D 20,000 20,000     -
   Baroldi Paolo SVP & Chief Medical Officer   •       –      –    2017-01-03 4 S $15.51 $252,776 D/D (16,300) 54,365     -
   Baroldi Paolo SVP & Chief Medical Officer   •       –      –    2017-01-03 4 OE $0.00 $0 D/D 30,000 70,665     -
   Gulino Richard L. SVP, General Counsel & Sec.   •       –      –    2017-01-03 4 S $15.51 $169,090 D/D (10,900) 9,100     -
   Gulino Richard L. SVP, General Counsel & Sec.   •       –      –    2017-01-03 4 OE $0.00 $0 D/D 20,000 20,000     -
   Polymeropoulos Mihael Hristos President and CEO   •       •      –    2017-01-03 4 S $15.48 $361,242 D/D (23,330) 850,848     -
   Polymeropoulos Mihael Hristos President and CEO   •       •      –    2017-01-03 4 OE $0.00 $0 D/D 50,000 874,178     -
   Polymeropoulos Mihael Hristos President and CEO   •       •      –    2016-12-23 5 GD $0.00 $0 D/D 9,000 830,178     -
   Deerfield Special Situations Fund, L.p. Possible Member of 10% Group   –       –       •   2016-09-23 4 S $16.71 $13,023,056 I/I (779,497) 693,171     -
   Deerfield Special Situations Fund, L.p. Possible Member of 10% Group   –       –       •   2016-09-22 4 S $16.24 $5,536,914 I/I (340,964) 850,778     -
   Deerfield Special Situations Fund, L.p. Possible Member of 10% Group   –       –       •   2016-09-19 4 S $15.53 $713,279 I/I (45,811) 919,718     -
   Deerfield Special Situations Fund, L.p. Possible Member of 10% Group   –       –       •   2016-09-16 4 S $15.62 $4,691,510 I/I (300,372) 956,762     -
   Deerfield Special Situations Fund, L.p. Possible Member of 10% Group   –       –       •   2016-09-15 4 S $15.76 $3,177,831 I/I (201,703) 1,044,620     -
   Polymeropoulos Mihael Hristos President and CEO   •       •      –    2016-01-04 4 S $8.96 $191,323 D/D (21,353) 839,178     -
   Polymeropoulos Mihael Hristos President and CEO   •       •      –    2016-01-04 4 OE $0.00 $0 D/D 43,750 860,531     -
   Baroldi Paolo SVP & Chief Medical Officer   •       –      –    2016-01-04 4 S $8.96 $110,925 D/D (12,380) 40,665     -
   Baroldi Paolo SVP & Chief Medical Officer   •       –      –    2016-01-04 4 OE $0.00 $0 D/D 22,500 53,045     -
   Polymeropoulos Mihael Hristos President and CEO   •       •      –    2015-12-28 5 GD $0.00 $0 D/D 15,000 801,781     -
   Deerfield Special Situations Fund, L.p. Possible Member of 10% Group   –       –       •   2015-12-16 4 B $8.97 $100,156 I/I 11,170 1,103,617 1.5     -
   Deerfield Special Situations Fund, L.p. Possible Member of 10% Group   –       –       •   2015-12-11 4 B $8.61 $2,779,573 I/I 322,872 1,100,378 1.5     -
   Deerfield Special Situations Fund, L.p. Possible Member of 10% Group   –       –       •   2015-12-10 4 B $8.59 $885,736 I/I 103,110 1,006,744 1.5     -
  549 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 10 of 22
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us